glp-1 deficiency Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology Research has associated GLP-1 medications

Noom Partners in Safety News and Updates Based on an analysis of self-reported data from 1,185 engaged Noom GLP-1Rx Program users with a BMI of 25 or greater

The problem is that most guides out there bury this information under pages of generic background, leaving researchers to piece together their own timelines from scattered clinical trial data and forum posts

Lancet 374:16061616 Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gmez R, Muoz RM, Eng J, Blzquez E (2000) Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

But when food intake is limited, prioritizing soluble fiber tends to produce better results because it directly addresses the primary problem, stool that has become too hard and dry